Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
Rheumatoid Arthritis
•
General Rheumatology
•
JAK Inhibitors
•
Gastroenterology
•
Cirrhosis
•
Hepatology
Do you avoid JAK inhibitors in patients with a history of liver disease including NAFLD or cirrhosis?
Related Questions
Have you utilized JAK inhibitors in patients on dialysis?
In what clinical situations do you consider azathioprine for treatment of inflammatory arthritis?
Do you avoid peritoneal dialysis in cirrhotic patients with ascites?
What is the role of inebilizumab in the maintenance treatment of IgG4-related disease?
What patient factors guide your selection of maintenance therapies for a patient with autoimmune hepatitis?
How would you approach diagnosis of a patient with recurrent episodes of abdominal pain, severe myalgias, low grade fevers and urticaria?
What is your approach to methotrexate use (or avoidance) in patients with varying MTHFR mutations?
Would you consider long term avatrombopag use in patients with cirrhosis requiring higher platelet counts for medical therapy?
How do you manage transaminitis in a patient receiving TNF alpha inhibitors?
How do you guide patients who seek online information about their disease to ensure it is accurate, supports their understanding, and minimizes unnecessary anxiety?
